These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 3261813
1. [Successful immunotherapy of malignant hemangioendothelioma using recombinant interleukin-2]. Masuzawa M, Higashi K, Nishioka K, Nishiyama S. Nihon Hifuka Gakkai Zasshi; 1988 Mar; 98(3):367-9. PubMed ID: 3261813 [No Abstract] [Full Text] [Related]
2. [A dramatic effect of continuous intra-arterial injected recombinant interleukin-2 immunotherapy on malignant hemangioendothelioma]. Takano M, Suzuki Y, Asai T, Masuzawa M, Nishiyama S. Nihon Hifuka Gakkai Zasshi; 1991 Jun; 101(7):719-25. PubMed ID: 1942580 [Abstract] [Full Text] [Related]
3. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2]. Fujioka A, Sezai Y. Nihon Hifuka Gakkai Zasshi; 1991 Aug; 101(9):959-63. PubMed ID: 1942594 [Abstract] [Full Text] [Related]
4. A case of malignant haemangioendothelioma showing response to interleukin 2 therapy. Inadomi T, Fujioka A, Suzuki H. Br J Dermatol; 1992 Oct; 127(4):442-3. PubMed ID: 1419766 [No Abstract] [Full Text] [Related]
5. Malignant angioendothelioma--effect of immunotherapy with Corynebacterium parvum. Tan SG, Cotterill JA, Roberts MM, Cunliffe WJ. Acta Derm Venereol; 1978 Oct; 58(6):551-3. PubMed ID: 83086 [No Abstract] [Full Text] [Related]
6. Spindle cell hemangioendothelioma: successful treatment with recombinant interleukin-2. Setoyama M, Shimada H, Miyazono N, Baba Y, Kanzaki T. Br J Dermatol; 2000 Jun; 142(6):1238-9. PubMed ID: 10848757 [No Abstract] [Full Text] [Related]
7. A case of malignant haemangioendothelioma treated with recombinant interleukin-2. Ansai S, Goto K, Aoki T, Hozumi Y, Aso K. Clin Exp Dermatol; 1993 Sep; 18(5):470-5. PubMed ID: 8252775 [Abstract] [Full Text] [Related]
9. Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy. Ohguri T, Imada H, Nomoto S, Yahara K, Hisaoka M, Hashimoto H, Tokura Y, Nakamura K, Shioyama Y, Honda H, Terashima H, Moroi Y, Furue M, Korogi Y. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1446-53. PubMed ID: 15817349 [Abstract] [Full Text] [Related]
10. [A case of malignant hemangioendothelioma effectively treated with intra-arterial continuous infusion of interleukin-2]. Fujioka A, Sugitani M, Suzuki Z, Tokita J, Yorimitsu K, Sezai Y. Gan To Kagaku Ryoho; 1991 Aug 01; 18(11):1958-61. PubMed ID: 1877838 [Abstract] [Full Text] [Related]
11. Cutaneous malignant hemangioendothelioma: clinical and histopathological observations of nine patients and a review of the literature. Bhutto AM, Uehara K, Takamiyagi A, Hagiwara K, Nonaka S. J Dermatol; 1995 Apr 01; 22(4):253-61. PubMed ID: 7608382 [Abstract] [Full Text] [Related]
19. [Pneumothorax due to pulmonary metastasis from malignant hemangioendothelioma of the scalp--a case report]. Ohno K, Nakahara K, Kitagawa Y, Yang DS, Kawashima Y. Nihon Kyobu Geka Gakkai Zasshi; 1987 Nov 01; 35(11):2036-9. PubMed ID: 3328757 [No Abstract] [Full Text] [Related]